相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apoptosis inhibitor of macrophage (AIM) diminishes lipid droplet-coating proteins leading to lipolysis in adipocytes
Yoshihiro Iwamura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients
Mayu Ohnishi et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis
Jeffrey A. Handy et al.
BIOCHEMICAL JOURNAL (2011)
Selection of the appropriate method for the assessment of insulin resistance
Anwar Borai et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
AIMing at Metabolic Syndrome - Towards the Development of Novel Therapies for Metabolic Diseases via Apoptosis Inhibitor of Macrophage (AIM)
Toru Miyazaki et al.
CIRCULATION JOURNAL (2011)
Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy
Yoshito Itoh et al.
HEPATOLOGY RESEARCH (2011)
Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue
Jun Kurokawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Serum Levels of Adipokines in Patients with Chronic HCV Infection: Relationship with Steatosis and Fibrosis
Arzu Tiftikci et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease
Joe Gray et al.
BMC CANCER (2009)
Adipokines in Liver Diseases
Fabio Marra et al.
HEPATOLOGY (2009)
Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis
Rami Moucari et al.
GASTROENTEROLOGY (2008)
Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C
Ian Homer Y. Cua et al.
HEPATOLOGY (2008)
Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
Donna L. White et al.
JOURNAL OF HEPATOLOGY (2008)
Adipokines and Insulin Resistance
Katja Rabe et al.
MOLECULAR MEDICINE (2008)
Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity
Emmanuel Tsochatzis et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection
Angela Dolganiuc et al.
GASTROENTEROLOGY (2007)
Novel serum biomarker candidates for liver fibrosis in hepatitis C patients
Bevin Gangadharan et al.
CLINICAL CHEMISTRY (2007)
Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines
Ian Homer Y. Cua et al.
HEPATOLOGY (2007)
Clinical implications of hepatic steatosis in patients with chronic hepatitis C:: A multicenter study of US Veterans
Ke-Qin Hu et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans
E. Novo et al.
GUT (2006)
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: A meta-analysis of individual patient data
Gioacchino Leandro et al.
GASTROENTEROLOGY (2006)
Adipocytokines: leptin - the classical, resistin - the controversical, adiponectin - the promising, and more to come
A Koerner et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Adiponectin and its receptors in patients with chronic hepatitis C
JR Jonsson et al.
JOURNAL OF HEPATOLOGY (2005)
Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C
CJ Liu et al.
JOURNAL OF HEPATOLOGY (2005)
Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients
A Muzzi et al.
JOURNAL OF HEPATOLOGY (2005)
Impact of steatosis on progression of fibrosis in patients with mild hepatitis C
L Fartoux et al.
HEPATOLOGY (2005)
Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States
KQ Hu et al.
JOURNAL OF HEPATOLOGY (2004)
Management of chronic hepatitis C virus infection: a new era of disease control
NC Teoh et al.
INTERNAL MEDICINE JOURNAL (2004)
The severity of liver fibrosis is associated with high leptin levels in chronic Hepatitis C
T Piche et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
JM Hui et al.
GASTROENTEROLOGY (2003)
Relationship between the histological degrees of hepatitis and the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis C
K Matsumoto et al.
HEPATOLOGY RESEARCH (2002)
Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver
H Honda et al.
HEPATOLOGY (2002)
High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis
V Paradis et al.
HEPATOLOGY (2001)
Association of AIM, a novel apoptosis inhibitory factor, with hepatitis via supporting macrophage survival and enhancing phagocytotic function of macrophages
I Haruta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Nonalcoholic steatohepatitis: Definition and pathology
EM Brunt
SEMINARS IN LIVER DISEASE (2001)
分享论文
